Literature DB >> 18281056

Protection of IgE-mediated allergic sensitization by active immunization with IgE loops constrained in GFP protein scaffold.

Swey-Shen Chen1, Teresa Barankiewicz, Yong-Min Yang, Maurizio Zanetti, Paul Hill.   

Abstract

Green fluorescent protein (GFP) exhibits a rigid central beta-barrel, formed by eleven beta-strands with floppy loops spanning between the stands. Herein, we evaluate whether the rigid beta-barrel may serve as a scaffold that can constrain the loops of a foreign protein, and thus its antigenicity. The spanning loops, site 6 of GFP, were engineered with RE cloning sites for inserting oligonucleotides corresponding to FcepsilonRI-binding sequence of human IgE. In a high-throughput format, shortened oligonucleotides encoding eight amino acid residues of the receptor-binding regions were inserted into site 6 of GFP by PCR, followed by enabling sequences for in vitro transcription and translation at the 5' end. Antigenized C2-3 linker (C2-3L) was shown by immuno-blots with polyclonal anti-IgE under native gel electrophoresis and transfer. Recombinant antigenized GFP was expressed and purified to homogeneity by metal affinity column, followed by Sephacryl S-200 high resolution gel filtration. Hyperimmune sera from mice immunized with C2-3L antigenized GFP contain anti-IgE reactive with JW8 murine/human chimeric IgE. Further, elevated serum anti-C2-3L and affinity pure antibodies effectively inhibits binding of JW8 IgE to recombinant FcepsilonRIalpha, and desensitizes JW8 to rat RBL-2H3 transfected with human FcepsilonRIalpha. This observation raised the possibility that active IgE vaccine may be employed in raising active protective anti-IgE in allergic patients as an alternative to passive immunization with MAb-E25 anti-IgE. Taken together, GFP appears suitable protein scaffold for spanning/constraining the C2-3L of human IgE as active vaccine; and this technique may be generally employed for eliciting antibodies to specific B-cell epitopes of other proteins.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18281056     DOI: 10.1016/j.jim.2007.10.007

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  SplitCore Technology Allows Efficient Production of Virus-Like Particles Presenting a Receptor-Contacting Epitope of Human IgE.

Authors:  A Zh Baltabekova; Zh S Shagyrova; A S Kamzina; M Voykov; Ye Zhiyenbay; E M Ramanculov; A V Shustov
Journal:  Mol Biotechnol       Date:  2015-08       Impact factor: 2.695

2.  Development of a functional antibody by using a green fluorescent protein frame as the template.

Authors:  Rongzhi Wang; Shuangshuang Xiang; Yonghui Zhang; Qiuyu Chen; Yanfang Zhong; Shihua Wang
Journal:  Appl Environ Microbiol       Date:  2014-05-02       Impact factor: 4.792

3.  Immunogenicity of a peptide-based anti-IgE conjugate vaccine in non-human primates.

Authors:  Risini D Weeratna; Ghania Chikh; Lu Zhang; James D Fraser; Jennifer M Thorn; James R Merson; Michael J McCluskie; Brian R Champion; Heather L Davis
Journal:  Immun Inflamm Dis       Date:  2016-04-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.